MMP7 and myeloid sarcoma: Our findings confirmed the presence of (pro)MMP7 in activated microglia/macrophages in active MS lesions, and in addition immunohistochemical and Western blot analysis revealed that MMP7 expression was reduced in chronic active and inactive lesions, that is, where fibronectin aggregates are prominently present, compared with control white matter and remyelinated MS lesions.